Glass Particle Formation and Delamination in Pharmaceutical Glass Vials
Posted on July 28, 2019
Zai-Qing Wen, Vice President
Generon Biomedical Technology, Shanghai
Yasser Nashed-Samuel, Principal Scientist
Amgen Inc.
Kiyoshi Fujimori, Scientist
Amgen Inc.
Christopher Sloey, Senior Scientist
Amgen Inc.
Shawn Cao, Scientific Director
Amgen Inc.
Gianpiero Torraca, Senior Scientist
Amgen Inc.
Hans Lee, Chemistry Professor
Los Angeles Trade-Technical College
Margaret S. Ricci, Executive Director
Amgen Inc.
Linda Narhi, Consultant
Amgen Inc.
Joseph Phillips, Senior Vice President
ArmaGen
Abstract For decades, glass vials served as a standard primary container of choice for storing therapeutic products. However, recent observations of glass particles in commercial drug product vials have led to product quality issues, patient safety concerns, and even product recalls. This review art...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
glass delamination, Glass Particle Formation, glass vial manufacturing, Glass Vials
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
